Efficacy and safety of photodynamic therapy for cervical intraepithelial neoplasia: A systemic review

Photodiagnosis and Photodynamic Therapy

Volumn 11, Issue 2, 2014, Pages 104-112

  Tao, Xiao Hua ^a   Guan, Yang ^b   Shao, Dan ^a   Xue, Wei ^a   Ye, Fa Shun ^a   Wang, Ming ^a   He, Mei Hua ^a  

^a NANCHANG UNIVERSITY   (China)

^b Shenzhen Chronic Disease Hospital   (China)

Author keywords

Cervical intraepithelial neoplasia; Photodynamic therapy; Review

Indexed keywords

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; PLACEBO;

CANCER RECURRENCE; CLINICAL EFFECTIVENESS; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; LIGHT; MINIMALLY INVASIVE PROCEDURE; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA IN SITU; VIRAL CLEARANCE; WART VIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; INCIDENCE; META ANALYSIS; MORTALITY; PHOTOCHEMOTHERAPY; RADIATION INJURY; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; INCIDENCE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RADIATION INJURIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84901588699     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2014.02.012     Document Type: Review

References (37)

1. Martin C.M., O'Leary J.J. Histology of cervical intraepithelial neoplasia and the role of biomarkers. Best Pract Res Clin Obstet Gynaecol 2011, 25(5):605-615.
2. Spitzer M., Apgar B.S., Brotzman G.L. Management of histologic abnormalities of the cervix. Am Fam Physician 2006, 73(1):105-112.
3. Ostör A.G. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993, 12(2):186-192.
4. Walboomers J.M., Jacobs M.V., Manos M.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189(1):12-19.
5. Wang-Johanning F., Lu D.W., Wang Y., Johnson M.R., Johanning G.L. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis. Cancer 2002, 94(8):2199-2210.
6. Trottier H., Franco E.L. Human papillomavirus and cervical cancer: burden of illness and basis for prevention. Am J Manag Care 2006, 12(17 Suppl.):S462-S472.
7. de Sanjose S., Diaz M., Castellsague X., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7(7):453-459.
8. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90.
9. International Agency for Research on Cancer. Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed. Available at: (accessed 12.12.13). http://www.iarc.fr/en/media-centre/pr/2013/pdfs/pr223_E.pdf.
10. Cox J.T. Management of cervical intraepithelial neoplasia. Lancet 1999, 353(9156):857-859.
11. Petry K.U. Management options for cervical intraepithelial neoplasia. Best Pract Res Clin Obstet Gynaecol 2011, 25(5):641-651.
12. Saslow D., Solomon D., Lawson H.W., et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012, 137(4):516-542.
13. Nene B.M., Hiremath P.S., Kane S., Fayette J.M., Shastri S.S., Sankaranarayanan R. Effectiveness, safety, and acceptability of cryotherapy by midwives for cervical intraepithelial neoplasia in Maharashtra, India. Int J Gynaecol Obstet 2008, 103(3):232-236.
14. Hillemanns P., Korell M., Schmitt-Sody M., et al. Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Int J Cancer 1999, 81(1):34-38.
15. Soergel P., Makowski L., Makowski E., Schippert C., Hertel H., Hillemanns P. Treatment of high grade cervical intraepithelial neoplasia by photodynamic therapy using hexylaminolevulinate may be costeffective compared to conisation procedures due to decreased pregnancy-related morbidity. Lasers Surg Med 2011, 43(7):713-720.
16. Oxford Centre for Evidence-based Medicine. Levels of Evidence March 2009, Available at: http://wwwcebmnet/indexaspx?o=1025 (accessed 06.12.12).
17. Barnett A.A., Haller J.C., Cairnduff F., Lane G., Brown S.B., Roberts D.J. A randomised, double-blind, placebo-controlled trial of photodynamic therapy using 5-aminolaevulinic acid for the treatment of cervical intraepithelial neoplasia. Int J Cancer 2003, 103(6):829-832.
18. Soergel P., Loehr-Schulz R., Hillemanns M., Landwehr S., Makowski L., Hillemanns P. Effects of photodynamic therapy using topical applied hexylaminolevulinate and methylaminolevulinate upon the integrity of cervical epithelium. Lasers Surg Med 2010, 42(9):624-630.
19. Bodner K., Bodner-Adler B., Wierrani F., et al. Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: a comparison of preliminary results. Anticancer Res 2003, 23(2C):1785-1788.
20. Ichimura H., Yamaguchi S., Kojima A., et al. Eradication and reinfection of human papillomavirus after photodynamic therapy for cervical intraepithelial neoplasia. Int J Clin Oncol 2003, 8(5):322-325.
21. Wierrani F., Kubin A., Jindra R., et al. 5-Aminolevulinic acid-mediated photodynamic therapy of intraepithelial neoplasia and human papillomavirus of the uterine cervix - a new experimental approach. Cancer Detect Prev 1999, 23(4):351-355.
22. Chen M.K., Luo D.Q., Zhou H., Huang Z.W., Zhang Q.F., Han J.D. 5-Aminolevulinic acid-mediated photodynamic therapy on cervical condylomata acuminata. Photomed Laser Surg 2011, 29(5):339-343.
23. Soergel P., Wang X., Stepp H., Hertel H., Hillemanns P. Photodynamic therapy of cervical intraepithelial neoplasia with hexaminolevulinate. Lasers Surg Med 2008, 40(9):611-615.
24. Yamaguchi S., Tsuda H., Takemori M., et al. Photodynamic therapy for cervical intraepithelial neoplasia. Oncology 2005, 69(2):110-116.
25. Istomin Y.P., Lapzevich T.P., Chalau V.N., Shliakhtsin S.V., Trukhachova T.V. Photodynamic therapy of cervical intraepithelial neoplasia grades II and III with Photolon. Photodiagnosis Photodyn Ther 2010, 7(3):144-151.
26. Keefe K.A., Tadir Y., Tromberg B., et al. Photodynamic therapy of high-grade cervical intraepithelial neoplasia with 5-aminolevulinic acid. Lasers Surg Med 2002, 31(4):289-293.
27. Wang J., Xu J., Chen J., et al. Successful photodynamic therapy with topical 5-aminolevulinic acid for five cases of cervical intraepithelial neoplasia. Arch Gynecol Obstet 2010, 282(3):307-312.
28. Martin-Hirsch P.L., Whitehurst C., Buckley C.H., Moore J.V., Kitchener H.C. Photodynamic treatment for lower genital tract intraepithelial neoplasia. Lancet 1998, 351(9113):1403.
29. Monk B.J., Brewer C., VanNostrand K., et al. Photodynamic therapy using topically applied dihematoporphyrin ether in the treatment of cervical intraepithelial neoplasia. Gynecol Oncol 1997, 64(1):70-75.
30. Hillemanns P., Wang X., Hertel H., et al. Pharmacokinetics and selectivity of porphyrin synthesis after topical application of hexaminolevulinate in patients with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2008, 198(3):300. e1-7.
31. Demidova T.N., Hamblin M.R. Photodynamic therapy targeted to pathogens. Int J Immunopathol Pharmacol 2004, 17(3):245-254.
32. Hornung R. Photomedical approaches for the diagnosis and treatment of gynecologic cancers. Curr Drug Targets Immune Endocr Metabol Disord 2001, 1(2):165-177.
33. Sandell J.L., Zhu T.C. A review of in-vivo optical properties of human tissues and its impact on PDT. J Biophotonics 2011, 4(11-12):773-787.
34. Regula J., MacRobert A.J., Gorchein A., et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX-a pilot study. Gut 1995, 36(1):67-75.
35. Townsend D.E. Cervical crypt involvement by intraepithelial neoplasia. Obstet Gynecol 1981, 57(4):546.
36. Pahernik S.A., Botzlar A., Hillemanns P., et al. Pharmacokinetics and selectivity of aminolevulinic acid-induced porphyrin synthesis in patients with cervical intra-epithelial neoplasia. Int J Cancer 1998, 78(3):310-314.
37. Kocken M., Helmerhorst T.J., Berkhof J., et al. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study. Lancet Oncol 2011, 12(5):441-450.